Eline Picavet

Orphan Drugs for Rare Diseases

Steven Simoens, David Cassiman, Marc Dooms et al. · Drugs · 2012 · 78 citations

Orphan Drugs, Drug Repositioning, Pharmacology +6

Shining a light in the black box of orphan drug pricing

Eline Picavet, Thomas Morel, David Cassiman et al. · Orphanet Journal of Rare Diseases · 2014 · 59 citations · Full text

Drugs for Rare Diseases: Influence of Orphan Designation Status on Price

Eline Picavet, Marc Dooms, David Cassiman et al. · Applied Health Economics and Health Policy · 2011 · 51 citations

Preclinical Therapeutics, Rare Diseases, Health Economics +6

Market uptake of orphan drugs - a European analysis

Eline Picavet, Lieven Annemans, Irina Cleemput et al. · Journal of Clinical Pharmacy and Therapeutics · 2012 · 34 citations

Clinical evidence for orphan medicinal products-a cause for concern?

Eline Picavet, David Cassiman, Carla E. M. Hollak et al. · Orphanet Journal of Rare Diseases · 2013 · 31 citations · Full text